Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

SELL
$7.12 - $20.24 $23,624 - $67,156
-3,318 Reduced 9.87%
30,313 $604,000
Q2 2022

Jul 25, 2022

BUY
$5.1 - $10.0 $102,984 - $201,930
20,193 Added 150.27%
33,631 $231,000
Q1 2022

May 02, 2022

BUY
$8.34 - $14.69 $1,200 - $2,115
144 Added 1.08%
13,438 $124,000
Q4 2021

Jan 28, 2022

BUY
$13.6 - $24.89 $180,798 - $330,887
13,294 New
13,294 $189,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.